Company / AR per Share
Vertex Pharmaceuticals AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$7.99
FY2025
5-year range
$4.37 / $7.99
FY2021-FY2025
Trend
+27.9%
vs FY2024
Sector context
#9 of 113
Health Care
What the data says
Among 113 Health Care companies, Vertex Pharmaceuticals is in the top 8% for ar per share. AR per Share has increased for 9 consecutive years, from $0.81 in FY2016 to $7.99 in FY2025.
Based on SEC 10-K filings.
7.99 in FY2025 with a 5-year CAGR of +18.5%. Top quartile in the Health Care sector.
Improved from $6.08 to $7.99 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 113This company $7.99 Sector average $28.83
▼
-72.3% below sector average
Key checks
Key Insights
- Vertex Pharmaceuticals's ar per share has grown for 9 consecutive years.
- In FY2025, ar per share increased 27.9% year-over-year.
- Ranks #9 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.99 | +27.9% |
| FY2024 | $6.25 | +2.7% |
| FY2023 | $6.08 | +7.3% |
| FY2022 | $5.67 | +29.6% |
| FY2021 | $4.37 | +28.0% |
| FY2020 | $3.42 | +37.7% |
| FY2019 | $2.48 | +53.5% |
| FY2018 | $1.62 | +42.8% |
| FY2017 | $1.13 | +39.3% |
| FY2016 | $0.81 | +13.1% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026